A double-blind, placebo-controlled study of OPC-41061 [tolvaptan] in the treatment of cardiac edema (congestive heart failure)
Phase of Trial: Phase III
Latest Information Update: 19 May 2016
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Registrational; Therapeutic Use
- Acronyms QUEST
- Sponsors Otsuka Pharmaceutical
- 06 Nov 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 06 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jul 2007 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History